A股、港股都涨了，白酒还有拉升空间，上证指数不会止步3500点。踏空的人很多，卖飞的人也很多， 大家都在许愿希望市场跌，作为对手盘，我们许愿市场涨。 大家都没有对错，只是立场。轻仓的盼跌，重仓的盼涨，大家怎么可能没有分歧，都是从个人的利益角 度罢了，谁也别笑话谁。 今日，上证指数随时剑指3500点了，一个长期困扰A股压力位，只有突破了才会有新的行情。 大盘指数没有问题。 当前，指数的节奏很简单，只需要快速拉升就行了。3500点需要直线拉升，而且大幅远离才叫站稳了， 不是说拉升到3600点就叫结束了。 如果想站稳3500点，上证指数必须突破4000点。就像站稳3000点需要往上拉升到3600点以上。这是震荡 向上的结构性问题，市场肯定会有急跌回调，所以要拉升回踩的空间。 慢牛就是进三退二，不会单边上涨，行业轮动拉升，指数震荡上行。大家都认为会跌的情况下，市场又 晃晃悠悠的到3500点了。 个人对指数很乐观，对股票没有想法。大家如果是股民可能会被误导，不要因为我看好指数就让您做出 持有股票的决定了，你的股票是100%会跟着指数上涨吗？ A股要迎来新一轮变盘了 一旦突破3500点，如果白酒、证券、地产共振反弹的情况 ...

Group 1 - The core viewpoint emphasizes that the A-share market has historically spent most of its time below the 3500-point mark, and the focus should not be solely on previous peaks like 6124 and 5178 points [1] - The Shanghai Composite Index's performance is compared to the US stock market, suggesting that a slow and steady growth ("slow bull") is preferable to irrational spikes seen in 2007 and 2015 [1][3] - The importance of the 3500-point level is highlighted, indicating that if the index can stabilize above this point, it would significantly impact the current market trend [3] Group 2 - The article suggests that the market is likely to accelerate upward, with the index expected to break through 3674 points, and the current market structure does not indicate a top [5] - It is noted that the white liquor sector is currently at a low point, which is seen as a positive factor for the market's potential recovery [3] - The analysis indicates that regardless of potential pullbacks, the overall trend remains upward, and any corrections would be limited in scope [5][7]

银河研究 金融期货研发报告 金融期货年报 2025 年 6 月 27 日 稳中有进 开启慢牛 ——股指期货 2025 年中策略报告 报告摘要： 2025 上半年市场两次经受住了考验，分别在政策预期、资金支撑下实现探底反弹，形 成快跌慢涨的慢牛走势，底部不断抬高。 一行一局一会两度联合新闻发布会，坚强有力的表态表明管理层稳定股市的信心和决 心，下半年政策环境持续稳定，股指也将表现稳定。 市场利率不断下行，理财资金不断转向高股息资产为股市营造良好的市场环境，推动中 长期资金入市的政策指向使保险资金股票投资不断提速，汇金等央企增持又使市场增添信 心，资金面整体稳中有增。 宏观经济数据和上市公司业绩同样保持平稳，进而使估值下有支撑，股指慢牛表现即有 基本面又有资金面的助力，预计下半年将继续震荡上行。 股指期货成交持仓略有增长，受多方因素影响贴水有所加大，为期指多头带来较好的投 资机会，在风险合理控制的情况下，可能为投资者取得超额收益。 风险因素：国内经济增长不及预期，地缘政治因素 研究员：孙锋 期货从业证号： F0211891 投资咨询从业证号： Z000567 :sunfeng@chinastock.com.cn ...

Core Viewpoint - The current state of the innovative drug market is uncertain, with investors questioning whether the recent downturn is a temporary fluctuation or a sign of a prolonged decline. The hope is for a gradual upward trend in the market [2][3]. Group 1: Market Dynamics - The innovative drug sector in China has only been active in the secondary market for seven years, experiencing significant volatility that typically takes decades in other industries. From 2020 to 2021, the sector saw explosive growth, with many companies doubling their stock prices, but this was followed by a sharp decline, reaching historical lows by July 2024, with most companies trading below their initial offering prices [3][4]. - The recent recovery in the Hong Kong stock market for innovative drugs began in early 2025, spurred by significant business development (BD) transactions involving companies like 3SBio and CSPC Pharmaceutical Group, leading to a bullish sentiment in the A-share market [4][5]. Group 2: Investment Sentiment - Despite the recent market recovery, caution is warranted as the previous surge taught investors that only a small fraction of the thousands of drug pipelines are securing large deals, raising concerns about market viability for many others [5][6]. - The innovative drug industry in China is recognized for its potential, even if much of its current innovation is in the form of fast-follow strategies. Recent record-breaking BD transactions and the emergence of the first domestic "billion-dollar molecule" demonstrate that Chinese innovation can gain international recognition [6][7]. Group 3: Future Outlook - The development of innovative drugs is a long-term endeavor, typically requiring an average of ten years and one billion dollars to bring a new drug to market. The industry is still in its growth phase, and the next decade is expected to see a more rational valuation from the capital market, with a call for patience and longer growth cycles [6][7]. - A stable policy environment is crucial for fostering a "slow bull" market in the innovative drug sector. Recent initiatives from the National Healthcare Security Administration to explore new payment models for innovative drugs and the reduction of clinical trial review times are seen as positive steps [7][8]. - A collaborative approach among companies, investors, and regulators, emphasizing long-termism, is essential for the emergence of more internationally competitive innovative drugs. A focus on steady progress rather than rapid growth is advocated to ensure sustainable development [8].

Group 1 - The China Securities Regulatory Commission (CSRC) has decided to temporarily suspend IPOs, but is implementing a pre-review mechanism for high-quality technology companies, indicating a cautious approach rather than a full opening of the IPO market [1] - The CSRC's actions can be seen as a signal to further support IPOs after encouraging mergers and acquisitions, suggesting a positive market sentiment and potential for a bull market [1] Group 2 - The A-share market has shown a downward trend, with the Shanghai Composite Index closing at 3362 points after a day of weak trading and a significant drop in trading volume to approximately 1.2 trillion [3] - There is a noticeable shift in market dynamics, with previously strong sectors like innovative pharmaceuticals and digital currencies experiencing declines, while underperforming sectors like humanoid robots saw a rebound [3] Group 3 - Over 4000 stocks in the A-share market declined, with a significant increase in selling pressure as the market showed weak performance, leading to a closing volume exceeding 56 billion [5] - The lack of strong buying support during the market's decline suggests that large funds are not currently inclined to intervene, which could lead to further downward pressure if the market continues to fall [5] Group 4 - The Shanghai Composite Index is at a critical turning point, with the 3330 to 3350 point range being particularly sensitive; if this range is breached, it could lead to more severe declines [6] - Historical patterns suggest that if the index can maintain this range, there may be potential for recovery, although current market conditions make predictions uncertain [6] Group 5 - The Shanghai Composite Index fell by 0.79%, while the ChiNext and Shenzhen Composite Indexes dropped by over 1% [7]

消息面，证监会副主席李明今日表示，今年以来，社保、保险、年金等中长期资金累计净买入A股超过 2000亿元，反映出中长期资金加速流入与股市稳中有涨的良性循环正在形成。 此外，上交所近日在京举办专场培训，针对商业银行理财公司权益类资金入市提供多维度的政策和实操 培训。上交所介绍，此次培训旨在全面贯彻落实"一行一局一会"联合出台的一揽子金融支持政策，充分 释放ETF在引入中长期资金方面的效能，持续壮大"长钱长投"规模。 盘面上，A500指数ETF（159351）成交活跃，全天成交突破22.94亿元，成交额位居全市场同类第二， 深市同类第一；换手率16.03%，位居全市场同类第二，深市第一。成分股继续表现活跃，宁波港、航 天彩虹、海格通信强势涨停，高能环境、科达制造涨超5%。 每经编辑｜曾子建 券商机构认为，今年A股大概率以"慢牛"方式运行，政策支持与经济基本面改善为市场提供支撑。近 期，中证A500指数虽小幅回调，但资金流入活跃、政策利好持续释放，叠加核心资产抗风险能力，跟 踪该指数相关产品中长期配置价值显著。 5月19日，A股市场延续窄幅震荡走势。到收盘时，沪指报3367.58点，微涨0.12%。场内热门宽基标的 ...

"虽然市场对本次发布会第一反应的超预期是央行'双降'，但我们认为随着关税冲击的显现，真正 能让经济和市场行稳致远的，仍在于货币金融政策和财政政策的协同。"招商基金预计，随着"一揽 子金融政策"在今年二季度的持续落地，三季度增量财政的空间也将随之打开。 上一次同样规格的新闻发布会发生在2024年9月24日，同样 是在上午盘前9点开始，同样是"一行一局一会"一把手出席， 同样是公布了一系列的金融支持政策，因此，市场自然会把这 两次新闻发布会进行对比。 作者： 邹永勤 封图：图虫创意 在5月7日国新办举行的新闻发布会上，中国人民银行（下称"央行"）行长潘功胜、金融监管总局 局长李云泽、中国证监会（下称"证监会"）主席吴清分别对"一揽子金融政策支持稳市场稳预期"的 有关情况进行了介绍，并答记者问。 "这是4月25日政治局会议'加强超常规逆周期调节'精神的落地。"广发证券资深宏观分析师钟林楠 向经济观察报记者表示，与去年四季度类似，这次央行、金融监管总局与证监会部署一揽子政策只 是一个开端，后续财政、准财政、消费、供给侧等领域应该还有进一步的政策空间。 "双降"或仅是开始 在发布会上，潘功胜宣布了央行的一揽子货币政策措 ...

Group 1 - The People's Bank of China announced a package of monetary policy measures, including a 0.5% reduction in the reserve requirement ratio, expected to provide approximately 1 trillion yuan in long-term liquidity [1][4] - A 0.1% decrease in the policy interest rate, lowering the 7-day reverse repurchase rate from 1.5% to 1.4%, is anticipated to lead to a similar decline in the Loan Prime Rate (LPR) [4] - The current A-share market is experiencing a combination of the new "Guo Jiu Tiao" policies and a "4 trillion" investment trend, with expectations for a continued "slow bull" market through 2025 [4] Group 2 - Historical data shows that A-share indices have generally increased following previous reserve requirement reductions since 2018, with significant gains observed after the two reductions in 2024 [4] - The financial sector, particularly large financial institutions, is expected to benefit directly from the liquidity easing, as evidenced by recent stock price increases in banks, securities, and insurance companies [4][6] - For the banking sector, the reserve requirement cut is expected to lower funding costs and alleviate pressure on net interest margins, while also stimulating corporate credit demand [6] - The securities industry is projected to see a recovery in profitability in 2025 due to sustained market liquidity, with a focus on brokers benefiting from increased investor participation and comprehensive leading brokers expected to benefit from supply-side reforms and potential mergers [6]

二、大资金突然出手，释放什么信号？ 无论是沪指还是创业板指数，今天的阳包阴主要出现在开盘半小时内。虽然沪指在这段时间涨幅不明显，但从盘面上能清楚看到大资金的强势动作。 低开后，市场迅速完成技术调整，一口气收复失地，这通常是多头强势的信号，也是市场突然变强的征兆。而这一切的导火索，正是沪深300ETF。 随着1.2万亿资金逐步通过银行体系流入市场，市场资金流动性得到有力补充，经济也迎来强劲动力。在这种充裕的资金环境下，消费市场迎来巨大机遇， 无论是高端消费还是日常消费，都能找到发展机会。 4月份有1000亿MLF到期，这意味着央行本月MLF净投放高达5000亿。很多人还没意识到这个数字的惊人之处。要知道，3月份MLF净投放才630亿，4月份 的投放量相当于3月份的近10倍，力度之大，简直就像"一次降准"！ 一、央行突击降准的牛市！降准降息是本次发布会重点之一，预计将向市场提供长期流动性约1万亿元！ 三、只要回踩基本上都会给我们一次比较好的这种分歧低吸的机会，短期我们就是轻指数、重个股、重节奏。 指数上，是低开之后出现了一波上攻，但是从量能上来看，1.2万亿的一个预期的成交量还是不太够，所以说下午仍然还是围绕33 ...

Policy Highlights - The People's Bank of China (PBOC) announced a 0.5% reduction in the reserve requirement ratio, releasing approximately 1 trillion yuan in long-term liquidity [1] - A targeted reserve requirement ratio cut to 0% for auto finance and financial leasing companies aims to enhance credit capacity in the automotive and equipment renewal sectors [1] - Policy interest rates were lowered by 0.1%, with the 7-day reverse repo rate decreasing from 1.5% to 1.4%, which is expected to drive down the Loan Prime Rate (LPR) [2] Financial Regulatory Measures - The Financial Regulatory Administration approved 6.7 trillion yuan in "white list" loans to support the construction and delivery of 16 million residential units [5] - A package of policies for small and micro enterprises was introduced, focusing on increasing credit supply, reducing costs, improving efficiency, and optimizing the environment [9] - Measures to stabilize the stock market include expanding insurance capital market participation with an additional 60 billion yuan for long-term investment [7] Capital Market Reforms - The China Securities Regulatory Commission (CSRC) is deepening reforms in the Sci-Tech Innovation Board and the Growth Enterprise Market to enhance institutional inclusivity and support mergers and acquisitions [12] - A high-quality development action plan for public funds was released, emphasizing the binding of fund and investor interests [13] - The introduction of a risk response plan aims to enhance the resilience of A-share listed companies against external shocks [14] Market Outlook - The combination of monetary easing and structural optimization is expected to stabilize market expectations and support long-term economic transformation, potentially leading to a slow bull market in A-shares [15] - The introduction of 8,000 billion yuan in technology innovation re-loans is anticipated to lower financing costs for tech companies, making them a core growth point in the market [17] - The public fund reform plan emphasizes long-term investment behavior, which is expected to reduce short-term volatility and enhance investor trust [18]